Generali Investments Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Generali Investments Management's REGN Position: Q2 2026 in Review
Generali Investments Management reduced its Regeneron Pharmaceuticals (REGN) stake by 38% in Q2 2026, selling an estimated $521K and leaving 1,276 shares worth $796K. The position accounts for 0.17% of the portfolio, ranked #87.
Generali Investments Management first reported a position in REGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.58M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Generali Investments Management held 1,276 shares of Regeneron Pharmaceuticals worth $796K as of Q2 2026.
- Generali Investments Management sold 766 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $521K.
- Regeneron Pharmaceuticals made up 0.17% of Generali Investments Management's portfolio in Q2 2026, its #87 holding.
- Generali Investments Management first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
- Generali Investments Management's Regeneron Pharmaceuticals position peaked at $1.58M in Q1 2026.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Generali Investments Management's 13F filing for Q2 2026, filed 10 Jul 2026.